Clinical Trial Update: Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating altered drug disposition and diagnostic biomarkers for chronic inflammatory liver disease in individuals with fatty liver. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Fatty Liver | Phase 1 | Status: COMPLETED